157 related articles for article (PubMed ID: 21810511)
21. [Treatment of advanced and/or metastatic colorectal cancer with bevacizumab in combination with oxaliplatin-based chemotherapy (Folfox7 regimen)].
Oukkal M; Djilat K; Hadjam RM; Mahgoun M; Bentabak K; Graba A; Smail N; Kaci NA; Ahmed RB; Bouzid K
Bull Cancer; 2010 Apr; 97(4):469-74. PubMed ID: 20385517
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant therapy for colon cancer in the new millenium.
Rao S; Cunningham D
Scand J Surg; 2003; 92(1):57-64. PubMed ID: 12705552
[TBL] [Abstract][Full Text] [Related]
23. [Predictive and prognostic value of MSI phenotype in adjuvant colon cancer: Who and how to treat?].
Zaanan A; Taieb J
Bull Cancer; 2019 Feb; 106(2):129-136. PubMed ID: 30527814
[TBL] [Abstract][Full Text] [Related]
24. Biological therapy and other novel therapies in early-stage disease: are they appropriate?
Grothey A
Clin Cancer Res; 2007 Nov; 13(22 Pt 2):6909s-12s. PubMed ID: 18006799
[TBL] [Abstract][Full Text] [Related]
25. Translating IDEA to Practice and Beyond: Managing Stage II and III Colon Cancer.
Gill S; Meyerhardt JA; Arun M; Veenstra CM
Am Soc Clin Oncol Educ Book; 2019 Jan; 39():226-235. PubMed ID: 31099666
[TBL] [Abstract][Full Text] [Related]
26. Optimal duration of adjuvant therapy for stage III colon cancer.
Kadakia KC; Worrilow WM; Coley H; Salem ME
Clin Adv Hematol Oncol; 2019 May; 17(5):289-298. PubMed ID: 31188808
[TBL] [Abstract][Full Text] [Related]
27. Targeted therapies as adjuvant treatment for early-stage colorectal cancer: first impressions and clinical questions.
Chibaudel B; Tournigand C; André T; Larsen AK; de Gramont A
Clin Colorectal Cancer; 2010 Dec; 9(5):269-73. PubMed ID: 21208840
[TBL] [Abstract][Full Text] [Related]
28. Prognostic and predictive roles of DNA mismatch repair status in colon cancer patients treated with oxaliplatin-based chemotherapy: a retrospective study.
Qin Q; Zhou AP; Yang L; Xu C; Sun YK; Zhang W; Wang JW; Zhong DS
J Physiol Pharmacol; 2020 Aug; 71(4):. PubMed ID: 33316771
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study.
Tougeron D; Mouillet G; Trouilloud I; Lecomte T; Coriat R; Aparicio T; Des Guetz G; Lécaille C; Artru P; Sickersen G; Cauchin E; Sefrioui D; Boussaha T; Ferru A; Matysiak-Budnik T; Silvain C; Karayan-Tapon L; Pagès JC; Vernerey D; Bonnetain F; Michel P; Taïeb J; Zaanan A
J Natl Cancer Inst; 2016 Jul; 108(7):. PubMed ID: 26839356
[TBL] [Abstract][Full Text] [Related]
30. National Surgical Adjuvant Breast and Bowel Project trials in colon cancer.
Wolmark N; Colangelo L; Wieand S
Semin Oncol; 2001 Feb; 28(1 Suppl 1):9-13. PubMed ID: 11273592
[TBL] [Abstract][Full Text] [Related]
31. Personalizing colon cancer adjuvant therapy: selecting optimal treatments for individual patients.
Dienstmann R; Salazar R; Tabernero J
J Clin Oncol; 2015 Jun; 33(16):1787-96. PubMed ID: 25918287
[TBL] [Abstract][Full Text] [Related]
32. Successes and limitations of targeted cancer therapy in colon cancer.
Köhne CH
Prog Tumor Res; 2014; 41():36-50. PubMed ID: 24727985
[TBL] [Abstract][Full Text] [Related]
33. Safety and Efficacy of Oxaliplatin Doublet Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer.
Brungs D; Aghmesheh M; de Souza P; Carolan M; Clingan P; Rose J; Ranson M
Clin Colorectal Cancer; 2018 Sep; 17(3):e549-e555. PubMed ID: 29861156
[TBL] [Abstract][Full Text] [Related]
34. Cetuximab plus FOLFOX-4 for fully resected stage III colon carcinoma: scientific background and the ongoing PETACC-8 trial.
Taieb J; Puig PL; Bedenne L
Expert Rev Anticancer Ther; 2008 Feb; 8(2):183-9. PubMed ID: 18279058
[TBL] [Abstract][Full Text] [Related]
35. [Multimodal therapy for colon cancer: state of the art].
Weber T; Link KH
Zentralbl Chir; 2011 Aug; 136(4):325-33. PubMed ID: 21863510
[TBL] [Abstract][Full Text] [Related]
36. [Chemotherapy of patients with colorectal carcinoma].
Punt CJ
Ned Tijdschr Geneeskd; 2005 Jun; 149(26):1441-7. PubMed ID: 16010954
[TBL] [Abstract][Full Text] [Related]
37. Chemotherapy usage patterns in a US-wide cohort of patients with metastatic colorectal cancer.
Abrams TA; Meyer G; Schrag D; Meyerhardt JA; Moloney J; Fuchs CS
J Natl Cancer Inst; 2014 Feb; 106(2):djt371. PubMed ID: 24511107
[TBL] [Abstract][Full Text] [Related]
38. Stromal organization as predictive biomarker for the treatment of colon cancer with adjuvant bevacizumab; a post-hoc analysis of the AVANT trial.
Zunder S; van der Wilk P; Gelderblom H; Dekker T; Mancao C; Kiialainen A; Putter H; Tollenaar R; Mesker W
Cell Oncol (Dordr); 2019 Oct; 42(5):717-725. PubMed ID: 31102145
[TBL] [Abstract][Full Text] [Related]
39. Current stages of adjuvant treatment of colon cancer.
Köhne CH
Ann Oncol; 2012 Sep; 23 Suppl 10():x71-6. PubMed ID: 22987996
[No Abstract] [Full Text] [Related]
40. Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.
Kim CG; Ahn JB; Jung M; Beom SH; Heo SJ; Kim JH; Kim YJ; Kim NK; Min BS; Koom WS; Kim H; Roh YH; Ma BG; Shin SJ
Ann Surg Oncol; 2017 Jan; 24(1):227-235. PubMed ID: 27699609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
